OCT has solid experience in oncology trials, we can assist our clients with oncology program development, deliver services for any part of a trial as a standalone service, or even rescue trials. OCT is a Contract Research Organization (CRO) in Central and Eastern Europe specializing in oncology clinical research development, OCT has had the opportunity to participate in a broad range of clinical research studies since our inception.  Historically, we have focused our efforts on supporting our clients who conduct the most complex clinical trials in the most challenging disease states in Russia, Ukraine, Belarus, Latvia, Lithuania, Estonia and Bulgaria.

Our diverse experience has encompassed a range of therapeutic areas, clinical trial phases, and study designs.

Taking into account OCT geography, we offer our sponsors the enrollment potential and solid expertise in managing oncology programs. It will take long till saturation in oncology trials will take place in countries in Central and Eastern Europe.

We have dozens of sites in our region where oncology trials can be placed. Centralized healthcare system contains a large database of patients with diagnosed conditions, and newly diagnosed patients are updated on a regular basis.

As a full service CRO, OCT can provide the services required to support clinical trials, offering extensive therapeutic experience across Phase I-IV clinical programs.  For oncology studies, where competition for patients and complexity of design are leading issues, we use our experience and relationships with sites to manage and support our clients’ efforts to meet enrollment goals.

We have experience in following indications:
  • Breast cancer
  • Prostate
  • Bladder
  • Bone Metastases
  • Colorectal
  • Head & Neck
  • Ovarian
  • Endometrial cancer

OCT team includes certified specialists, including oncologists with experience in clinical research as investigators or study coordinators. This allows us to provide solutions for oncology clinical trials, and consistently meet enrollment targets.

Please contact us if you want to know more about OCT experience in Clinical Trials in Oncology